Medullary Thyroid Cancer
Showing 1 - 25 of 33
Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA
Not yet recruiting
- Adrenal Cortical Carcinoma
- +3 more
- individualized mRNA neoantigen vaccine (mRNA-0523-L001)
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023
A Detailed Look At What Patients Experience In Medullary Thyroid
Not yet recruiting
- Medullary Thyroid Cancer
-
San Francisco, CaliforniaPower Life Sciences
Oct 6, 2023
Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)
Recruiting
- Medullary Thyroid Cancer
- Anlotinib Hydrochloride Capsule
-
Hefei, Anhui, China
- +18 more
Apr 14, 2023
Medullary Thyroid Cancer Trial in Worldwide (Cabozantinib (XL184) 140 mg, Cabozantinib (XL184) 60 mg, Placebo tablet)
Active, not recruiting
- Medullary Thyroid Cancer
- Cabozantinib (XL184) 140 mg
- +3 more
-
St. Leonards, New South Wales, Australia
- +49 more
Jan 23, 2023
Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)
Recruiting
- Medullary Thyroid Cancer
- Selpercatinib
- +2 more
-
Birmingham, Alabama
- +148 more
Jan 18, 2023
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun
Not yet recruiting
- RET-altered Non Small Cell Lung Cancer
- +3 more
-
Chang chun, Jilin, ChinaJinlin Province Cancer Hosipital
Dec 21, 2022
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)
Not yet recruiting
- Medullary Thyroid Cancer
- +3 more
-
Groningen, NetherlandsUniversity Medical Centre Groningen
Sep 8, 2022
Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)
Active, not recruiting
- Solid Tumor
- Medullary Thyroid Cancer
-
Guangzhou, Guangdong, China
- +12 more
May 9, 2022
Children and Adults With Medullary Thyroid Cancer
Recruiting
- Medullary Thyroid Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
-
Shanghai, Shanghai, China
- +1 more
Mar 17, 2022
Locally Advanced or Metastatic Medullary Thyroid Cancer, Medullary Thyroid Cancer Trial in Worldwide (Patient outreach,
Active, not recruiting
- Locally Advanced or Metastatic Medullary Thyroid Cancer
- Medullary Thyroid Cancer
- Patient outreach
- Vandetanib
-
St Leonards, Australia
- +33 more
Oct 20, 2021
NSCLC, Medullary Thyroid Cancer Trial (pralsetinib (BLU-667))
Approved for marketing
- Non-Small Cell Lung Cancer
- Medullary Thyroid Cancer
- pralsetinib (BLU-667)
- (no location specified)
Aug 9, 2021
Medullary Thyroid Cancer Trial in France (18F-DOPA)
Completed
- Medullary Thyroid Cancer
- 18F-DOPA
-
Bordeaux, France
- +4 more
Mar 5, 2021
Thyroid Neoplasia, Well-Differentiated Thyroid Cancer, Medullary Thyroid Cancer Trial in São Paulo (Laser ablation,
Recruiting
- Thyroid Neoplasia
- +3 more
- Laser ablation
- +2 more
-
São Paulo, BrazilInstituto do Cancer do Estado de São Paulo
Feb 23, 2021
Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal
Not yet recruiting
- Amyloid
- +3 more
- (no location specified)
Feb 15, 2021
18F-Fluorocholine PET/CT in Medullary Thyroid Cancer
Active, not recruiting
- Medullary Thyroid Cancer
- 18F-fluorocholine PET/CT
-
Ljubljana, SloveniaDepartment for nuclear medicine, University medical centre Ljubl
Nov 3, 2020
Medullary Thyroid Cancer, Colon Cancer Trial in New York (Tumor Genomic Analysis)
Suspended
- Medullary Thyroid Cancer
- Colon Cancer
- Tumor Genomic Analysis
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Oct 14, 2020
Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)
Terminated
- Malignant Melanoma
- +7 more
- Rovalpituzumab tesirine
- Dexamethasone
-
Gilbert, Arizona
- +29 more
Sep 21, 2020
Carcinoid Cancer, Neuroendocrine Tumors, Medullary Thyroid Cancer Trial in Los Angeles (68Ga DOTATATE)
No longer available
- Carcinoid Cancer
- +3 more
- 68Ga DOTATATE
-
Los Angeles, CaliforniaUCLA Hospital
Jul 23, 2020